← Back to your selection

Catalio Capital Management

Activity from announced rounds

Activity in this selectionHealthtech

Catalio Capital Management is an investment manager whose official company communications identify BigHat Biosciences and Basecamp Research.

Recorded funding activity

BigHat combines AI and synthetic biology to engineer antibody therapeutics. Basecamp builds biological models from genomic data for therapeutic design, while Enveda discovers biologically active molecules from nature. The financings represent different routes from biological data to experimental medicines.

Sources
Rounds participated in
5
Confirmed lead rounds
1
4 roles undisclosed
New companies
5
First participation on record · 0 follow-on
Funding in participating rounds
$519M
5 disclosed · full round size, not this investor’s share

By stage

Series B2
Growth1
Series C+1
Undisclosed1

By primary sector

Healthtech4
Biotech1

By country

United States4
Australia1

Rounds

5 in this selection
Evvy

Evvy combines at-home vaginal microbiome testing with clinician-reviewed results, personalized next steps and optional treatment and coaching for women’s health.

$40MSeries B
Lead
AdvanCell

AdvanCell develops targeted alpha radiopharmaceuticals for cancer using Lead-212, with integrated isotope supply and manufacturing.

$315MSeries D
Role not disclosed
9amHealth

AI-enabled virtual specialty care platform for managing high-cost chronic conditions

$26MSeries B
Role not disclosed
Imperative Care

Develops treatments for patients suffering from thromboembolic disease

$100MGrowth
Role not disclosed